{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:48:22Z","timestamp":1665593302452},"reference-count":0,"publisher":"Akademiai Kiado Zrt.","issue":"49","license":[{"start":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T00:00:00Z","timestamp":1607212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2020,12,6]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold> Az allergi\u00e1s betegs\u00e9gekben szenved\u0151 emberek sz\u00e1ma\n                    vil\u00e1gszerte, k\u00f6zt\u00fck Magyarorsz\u00e1gon is n\u00f6vekszik. Az eg\u00e9szs\u00e9g\u00fcgyi\n                    ell\u00e1t\u00f3rendszerek azon dolgoznak, hogy min\u00e9l hat\u00e9konyabban tudj\u00e1k felhaszn\u00e1lni a\n                    rendelkez\u00e9sre \u00e1ll\u00f3 forr\u00e1sokat. Az Allergic Rhinitis and its Impact on Asthma\n                    (ARIA) szervezet c\u00e9lja az allergi\u00e1s n\u00e1th\u00e1ban szenved\u0151 betegek ell\u00e1t\u00e1s\u00e1nak\n                    jav\u00edt\u00e1sa, szakmai aj\u00e1nl\u00e1sok k\u00e9sz\u00edt\u00e9se, aktualiz\u00e1l\u00e1sa. Ennek egyik m\u00f3dja\n                    integr\u00e1lt betegell\u00e1t\u00e1si utak kidolgoz\u00e1sa. C\u00e9lunk ezek hazai el\u00e9rhet\u0151v\u00e9 t\u00e9tele,\n                    az aj\u00e1nl\u00e1sok sz\u00e9les k\u00f6r\u0171 elterjeszt\u00e9se az Eur\u00f3pai Uni\u00f3 (EU) t\u00f6bbi tag\u00e1llam\u00e1hoz\n                    hasonl\u00f3an Magyarorsz\u00e1gon is. Az ARIA m\u00e1s nemzetk\u00f6zi innovat\u00edv szervezetek\n                    bevon\u00e1s\u00e1val olyan integr\u00e1lt betegell\u00e1t\u00e1si utakat fejlesztett ki, amelyek\n                    allergi\u00e1s n\u00e1tha, esetleg t\u00e1rsbetegs\u00e9ge, az asztma eset\u00e9n t\u00e1mogatj\u00e1k a kezel\u00e9st.\n                    Ezeket \u00fajgener\u00e1ci\u00f3s ir\u00e1nyelvek kidolgoz\u00e1sa \u00fatj\u00e1n alkott\u00e1k, amelyekhez\n                    felhaszn\u00e1lt\u00e1k a mobiltechnol\u00f3gi\u00e1b\u00f3l \u00e9s pollenkamra-vizsg\u00e1latokb\u00f3l sz\u00e1rmaz\u00f3 val\u00f3s\n                    evidenci\u00e1kat is. A gy\u00f3gyszeres ter\u00e1pia optimaliz\u00e1l\u00e1s\u00e1hoz a vizu\u00e1lis anal\u00f3g\n                    sk\u00e1l\u00e1n alapul\u00f3, \u00fagynevezett Mobil L\u00e9g\u00fati Figyel\u0151 H\u00e1l\u00f3zat algoritmus\u00e1t\n                    digitaliz\u00e1lt\u00e1k, \u00e9s val\u00f3s evidenci\u00e1k felhaszn\u00e1l\u00e1s\u00e1val tov\u00e1bb finom\u00edtott\u00e1k.\n                    Allerg\u00e9n immunter\u00e1pi\u00e1ra az ARIA a vil\u00e1gon els\u0151k\u00e9nt dolgozott ki integr\u00e1lt\n                    betegell\u00e1t\u00e1si utakat 2019-ben. A kezel\u00e9si ir\u00e1nyelvekhez val\u00f3 adherenciaszint\n                    alacsony, a betegek a t\u00fcneteik er\u0151ss\u00e9ge alapj\u00e1n m\u00f3dos\u00edtj\u00e1k a kezel\u00e9st. A\n                    flutikazon-propion\u00e1t\u2013azelasztin kombin\u00e1ci\u00f3 hat\u00e1sa er\u0151sebb az intranasalis\n                    kortikoszteroidok\u00e9n\u00e1l, m\u00edg az ut\u00f3bbi hat\u00e1sosabb az oralis\n                    H<jats:sub>1<\/jats:sub>-antihisztaminokn\u00e1l. A mobiltelefonokban t\u00e1rolt elektronikus napl\u00f3\n                    vagy m\u00e1s \u2019mobile health\u2019 (mHealth) eszk\u00f6z\u00f6k haszn\u00e1lata seg\u00edti a betegek\n                    kiv\u00e1laszt\u00e1s\u00e1t allerg\u00e9n immunter\u00e1pi\u00e1ra. Az ARIA \u00e1ltal javasolt algoritmus\n                    megfelel\u0151nek mutatkozott az allergi\u00e1s rhinitis kezel\u00e9s\u00e9re, ez\u00e9rt ezek az\n                    ir\u00e1nyelvek beker\u00fclnek integr\u00e1lt betegell\u00e1t\u00e1si utakba, \u00e9s r\u00e9sz\u00e9t fogj\u00e1k k\u00e9pezni\n                    az EU Eg\u00e9szs\u00e9g\u00fcgyi \u00e9s \u00c9lelmiszer-biztons\u00e1gi F\u0151igazgat\u00f3s\u00e1ga digitaliz\u00e1lt,\n                    szem\u00e9lyk\u00f6zpont\u00fa gondoz\u00e1si anyagainak. Az allerg\u00e9n immunter\u00e1pia hat\u00e9kony az\n                    inhalat\u00edv allerg\u00e9nek \u00e1ltal okozott allergi\u00e1s betegs\u00e9gekben, alkalmaz\u00e1s\u00e1t azonban\n                    korl\u00e1tozni kell gondosan v\u00e1logatott betegekre. Orv Hetil. 2020; 161(49):\n                    2059\u20132071.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold> The number of allergic patients is increasing all over the\n                    world, also in Hungary. Delivering effective and cost-effective health care is\n                    essential for all health care systems. ARIA (Allergic Rhinitis and its Impact on\n                    Asthma) aims to improve the care of patients who suffer from allergic rhinitis\n                    by setting up guidelines and updating them. Development of ICPs (integrated care\n                    pathways) can play an essential role in attaining this goal. Our aim is to make\n                    ICP-s developed by ARIA available also in Hungary, as is already the case in\n                    other countries of the European Union (EU). Together with other international\n                    initiatives, ARIA has worked out digitally-enabled ICPs to support care in\n                    allergic rhinitis and comorbid asthma. ICPs are based on new-generation\n                    guidelines using RWE (real-world evidence) from chamber studies and mobile\n                    technology. The MASK (Mobile Airways Sentinel NetworK) algorithm \u2013 based on\n                    visual analogue scale \u2013 was digitalized to support pharmacotherapy, and was\n                    refined by using RWE. ARIA was the first to develop ICPs for allergen\n                    immunotherapy (AIT) in 2019. Based on MASK data, patients did not follow\n                    guidelines and their adherence to treatment was poor. Patients would modify\n                    their treatments, depending on the disease control. The effect of fluticasone\n                    propionate\u2013azelastine combination is superior to intranasal corticosteroids\n                    which are superior to oral H<jats:sub>1<\/jats:sub>-antihistamines. Electronic diaries\n                    obtained from cell phones and other \u2019mobile health\u2019 (mHealth) devices help\n                    select patients for AIT. The ARIA algorithm for AR was found appropriate and no\n                    change is necessary. These guidelines will inform ICPs and will be included in\n                    the DG Sant\u00e9 digitally-enabled, person-centred care system. AIT is an effective\n                    treatment for allergic diseases caused by inhaled allergens. Its use should,\n                    however, be restricted to carefully selected patients. Orv Hetil. 2020; 161(49):\n                    2059\u20132071.<\/jats:p>","DOI":"10.1556\/650.2020.31919","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T02:22:58Z","timestamp":1607480578000},"page":"2059-2071","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["A 2019. \u00e9vi ARIA kezel\u00e9si ir\u00e1nyelvek magyar adapt\u00e1ci\u00f3ja \u00e9s a hazai alkalmaz\u00e1s lehet\u0151s\u00e9gei allergi\u00e1s rhinitisben"],"prefix":"10.1556","volume":"161","author":[{"given":"Helga","family":"Kraxner","sequence":"first","affiliation":[{"name":"1 \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, F\u00fcl-Orr-G\u00e9g\u00e9szeti \u00e9s Fej-Nyakseb\u00e9szeti Klinika, Semmelweis Egyetem, Budapest, Szigony u. 36., 1083"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andor","family":"Hirschberg","sequence":"additional","affiliation":[{"name":"2 \u00daj Szent J\u00e1nos K\u00f3rh\u00e1z \u00e9s Szakrendel\u0151, F\u00fcl-Orr-G\u00e9ge \u00e9s Sz\u00e1jseb\u00e9szeti Oszt\u00e1ly, \u00c9szak-K\u00f6z\u00e9p-budai Centrum, Budapest"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krist\u00f3f","family":"N\u00e9k\u00e1m","sequence":"additional","affiliation":[{"name":"3 Allergol\u00f3gia \u00e9s Immunol\u00f3gia Szakambulancia, Budai Irgalmasrendi K\u00f3rh\u00e1z, Budapest"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/161\/49\/article-p2059.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/161\/49\/article-p2059.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T01:14:02Z","timestamp":1633914842000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/161\/49\/article-p2059.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,6]]},"references-count":0,"journal-issue":{"issue":"49"},"URL":"https:\/\/doi.org\/10.1556\/650.2020.31919","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,6]]}}}